Oracle said it has “secured all the funding we need to fulfill our contract with OpenAI,” in a post on X at 21:01 GMT on 20 November. It called its “final capital raise earlier this month” the step that made it “the first hyperscaler fully funded for this investment cycle.”
That raise was $10 billion of common stock at $116.00 a share and $10 billion of notes, per Oracle’s prospectus supplement. The stock closed at $101.17 on Friday, 12.8% below that price, per Nasdaq (our arithmetic). Live price and key dates are on our Oracle stock page.
Important: not investment advice
This article is for information and education only. It is not investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy or sell any security, ETF, option or other financial product. FourWeekMBA is not a broker-dealer or a registered investment adviser. IPO shares, leveraged and inverse ETFs, and options carry significant risk, including the loss of your entire investment; leveraged and inverse ETFs reset daily and can lose value quickly. Prices, availability, fees and eligibility change and can differ by country and broker, so check the prospectus and your broker’s terms. Figures marked “our arithmetic” are our own calculations from the cited filings and may contain errors. Do your own research and consider speaking to a licensed financial professional before making any investment decision.
Business Pill · Free Cash Flow
An evergreen Business Engineer explainer. It teaches the general idea only and does not discuss this report.
The key insight: Oracle says its OpenAI contract is fully funded after November’s $10 billion of stock at $116.00 and $10 billion of notes; the stock closed Friday at $101.17, 12.8% below the offering price (filings, Nasdaq; our arithmetic).
What Oracle Said
“The financing we outlined at Oracle Investor Day, including vendor financing, is in place,” Oracle wrote. “Any further private discussions with vendors are just additional options. Our ability to deliver on our OpenAI contract does not depend on those discussions.”
It added that “any media reports that will come out and say the contrary are incorrect and wrong.” The post did not name a report.
On the build, Oracle said its Abilene campus “is nearly complete,” Shackelford, “our next gigawatt-scale campus, is fully permitted,” and the handover of Nvidia Vera Rubin racks “is on track for the coming weeks.”
Oracle repeated that it expects “positive free cash flow in the second half of FY2028” and said it is “targeting more than $30 billion in free cash flow in FY2029.” Reuters reported the post as the deal being fully funded after the final raise.

The Raises in Oracle’s Filings
Oracle’s 4 November 8-K says it sold 86,206,897 shares and that the stock offering closed on 4 November, alongside $10 billion of senior notes. Our earlier piece showed its 2046 notes priced at an 8.650% coupon.
Earlier, Oracle’s 10-Q says it “fully utilized” a $20 billion at-the-market program in the quarter to 31 August, issuing 141 million shares for net proceeds of $19.9 billion. Across these three filings that is $39.9 billion (our arithmetic).
CNBC reported in February that Oracle planned to raise $45 billion to $50 billion of gross proceeds during 2026 through debt and equity. The post did not say how much of the financing comes from vendors.
Against the Contracts
Oracle’s remaining performance obligations were $664 billion at 31 August, with about 13% expected as revenue over the next 12 months, per its 10-Q. The $39.9 billion is about 6% of that backlog (our arithmetic). The OpenAI work sits in our AI compute commitments tracker.
In the same quarter, cash from operations was $23.1 billion and capital spending $28.5 billion, for free cash flow of minus $5.4 billion, per the 10-Q. Customer prepayments raised deferred revenue by $11.4 billion.

What the Market Did
Oracle closed at $101.17, down 8.50%, before the post, per Nasdaq. After hours it traded at $103.72 at 5:22 p.m. ET, up 2.52%. At the close, its shares were worth about $314.6 billion on the filed share count plus the November shares (our arithmetic).
The Structural Read
As we read it, Oracle is answering a financing question with a timeline: funded now, positive free cash flow from the second half of fiscal 2028.
As we read it, the buyers of November’s new shares are the first test of that timeline, at 12.8% below their price.
Oracle, on X, 20 Nov 2026
“Oracle has secured all the funding we need to fulfill our contract with OpenAI”
Three Implications
FOR THE NOVEMBER BUYERS the stock closed at $101.17 against the $116.00 offering price (our arithmetic: 12.8% lower).
FOR THE BACKLOG $664 billion of remaining performance obligations, about 13% expected as revenue within 12 months (10-Q).
FOR CASH FLOW minus $5.4 billion of free cash flow in the quarter to 31 August, with a positive target for the second half of fiscal 2028 (10-Q; Oracle).
What Is Not Established
Oracle did not give the size of its vendor financing or name the vendors. It did not say which media reports it meant. The $39.9 billion counts only the three filings we read; Oracle has other securities outstanding, including mandatory convertible preferred stock, that we did not add.
The Bottom Line
Oracle says the OpenAI contract is fully funded after $10 billion of stock at $116.00 and $10 billion of notes in November. The stock closed Friday at $101.17, and Oracle’s next free-cash-flow marker is the second half of fiscal 2028.
Important: not investment advice
This article is for information and education only. It is not investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy or sell any security, ETF, option or other financial product. FourWeekMBA is not a broker-dealer or a registered investment adviser. IPO shares, leveraged and inverse ETFs, and options carry significant risk, including the loss of your entire investment; leveraged and inverse ETFs reset daily and can lose value quickly. Prices, availability, fees and eligibility change and can differ by country and broker, so check the prospectus and your broker’s terms. Figures marked “our arithmetic” are our own calculations from the cited filings and may contain errors. Do your own research and consider speaking to a licensed financial professional before making any investment decision.
97,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity.
A note on sourcing. Oracle’s statements are quoted from its post on X. Share counts, offering terms, backlog and cash flows are from Oracle’s SEC filings. Prices are Nasdaq’s official close and after-hours data. Oracle was not contacted for this piece. Totals, ratios and percentage changes are our arithmetic.
Sources: Oracle post on X, 20 Nov 2026 21:01 UTC: OpenAI contract fully funded; FCF targets · Oracle prospectus supplement (424B5), 2 Nov 2026: 86,206,897 shares at $116.00 · Oracle Form 8-K, 4 Nov 2026: $10B common stock offering closed 4 Nov; $10B senior notes · Oracle Form 10-Q, quarter ended 31 Aug 2026: ATM $19.9B, RPO $664B, cash flows, share count · Reuters report via Red Hot Singapore, 20 Nov 2026: Oracle says OpenAI deal fully funded · CNBC, 2 Feb 2026: Oracle plans $45B-$50B of 2026 gross proceeds · Nasdaq, ORCL official close and after-hours trade, 20 Nov 2026 · FourWeekMBA, 11 Nov 2026: Oracle 2046 notes at 8.650% (pricing term sheet)









